Alliance Pharma plc (AIM: APH), the international healthcare group, announces that, pursuant to the Company's annual grant of options to employees, the Board has issued options over an aggregate of 837,836 ordinary shares of 1 pence each in the Company, on the recommendation of the Company's Remuneration Committee, to the PDMRs detailed below.

Peter Butterfield, Chief Executive Officer, has been awarded 182,500 unapproved share options under the Company's 2015 Share Option Plan and, 344,931 share options have been granted pursuant to the Company's Long-Term Incentive Plan 2019.

Andrew Franklin, Chief Financial Officer, has been awarded 121,900 unapproved share options under the Company's 2015 Share Option Plan and, 188,505 share options have been granted pursuant to the Company's Long-Term Incentive Plan 2019.

The share options awarded under the 2015 Company Share Option Plan have all been granted with an exercise price of 58.2p, being the closing mid-market price on 28th of September 2022, and become exercisable on 28th of September 2025, being the third anniversary of the date of the grant. The awards granted under the 2019 Long Term Incentive Plan have been granted at nil-cost and also become exercisable on 28th of September 2025.

The vesting of these awards is subject to continued employment and the satisfaction of performance conditions based on EPS and TSR targets.

Contact:

Tel: + 44 (0)20 7260 1000

About Alliance

Alliance Pharma plc (AIM: APH) is an international healthcare group. Our purpose is to improve the lives of consumers and patients through making available a range of clinically valuable healthcare products.

Our core focus is on the marketing of Consumer Healthcare brands, complemented by a smaller Prescription Medicines business. In total, we hold marketing rights to around 80 brands, with revenues generated from a mix of direct, distributor and e-commerce sales.

Headquartered in the UK, the Group employs around 250 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics operations, we remain asset-light and focused on maximising the value of our brands.

(C) 2022 Electronic News Publishing, source ENP Newswire